Placement Announced
Slate Medicines placement
US$245m raised
Announced 17 Aug 2026
Advisers
Lead managers
Not disclosed
- Issuer
- Slate Medicines
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- JATT II Acquisition Corp placement Jun 2026 · US$225m · Biotech
- Odyssey Therapeutics IPO May 2026 · US$279m · Biotech
- Caldera Therapeutics placement Jul 2026 · US$278m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Attovia Therapeutics IPO Aug 2026 · US$289m · Biotech
Sources
- 17 Aug 2026 Press release (EX-99.1, exhibit), Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to sec.gov
- 18 Aug 2026 Slate Medicines to Merge With Fulcrum Therapeutics cooley.com